Matthew Silva to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Matthew Silva has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.027
-
Sitole M, Silva M, Spooner L, Comee MK, Malloy M. Telaprevir versus boceprevir in chronic hepatitis C: a meta-analysis of data from phase II and III trials. Clin Ther. 2013 Feb; 35(2):190-7.
Score: 0.027